ABSTRACT
Michael I. Luster, Dori R. Germolec, Christine G. Parks, Laura Blanciforti, Michael Kashon, and Robert W. Luebke
CONTENTS
11.1 Introduction .........................................................................................................................165 11.2 Diseases Associated with Immunosuppression ..................................................................166 11.3 Social and Economic Impact of Infectious Diseases and the Risk Assessment Process....168 11.4 Issues in Using Human Data in Immunotoxicology Risk Assessment..............................169 11.5 Immunodeficiency and Relationship to Infectious Disease ...............................................170
